Monck; Nathaniel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Monck; Nathaniel.The latest application filed is for "new tetracyclic 6 azapyrazinoindolines as 5ht2c receptor agonists for obesity".
- Monck; Nathaniel - Wokingham GB
- Monck; Nathaniel - Winnersh GB
| Patent | Date |
|---|---|
| Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity Grant 7,547,699 - Hebeisen , et al. June 16, 2 | 2009-06-16 |
| Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity Grant 7,323,466 - Bentley , et al. January 29, 2 | 2008-01-29 |
| New tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity App 20060252759 - Hebeisen; Paul ; et al. | 2006-11-09 |
| New morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity App 20060178510 - Bentley; Jonathan Mark ; et al. | 2006-08-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 